(2022). A phase 1 clinical trial to evaluate the safety and pharmacokinetic/pharmacodynamic characteristics of HSG4112 after multiple oral administration in healthy and obese adult subjects. WHO International Clinical Trials Registry Platform.
Chicago Zitierstil"A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic/pharmacodynamic Characteristics of HSG4112 After Multiple Oral Administration in Healthy and Obese Adult Subjects." WHO International Clinical Trials Registry Platform 2022.
MLA Zitierstil"A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic/pharmacodynamic Characteristics of HSG4112 After Multiple Oral Administration in Healthy and Obese Adult Subjects." WHO International Clinical Trials Registry Platform 2022.